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A B S T R A C T
Adventure therapy offers a prevention, early intervention, and treatment modality for people with
behavioural, psychological, and psychosocial issues. It can appeal to youth-at-risk who are often less
responsive to traditional psychotherapeutic interventions. This study evaluated Wilderness Adventure
Therapy (WAT) outcomes based on participants’ pre-program, post-program, and follow-up responses to
self-report questionnaires. The sample consisted of 36 adolescent out-patients with mixed mental health
issues who completed a 10-week, manualised WAT intervention. The overall short-term standardised
mean effect size was small, positive, and statistically signiﬁcant (0.26), with moderate, statistically
signiﬁcant improvements in psychological resilience and social self-esteem. Total short-term effects
were within age-based adventure therapy meta-analytic benchmark 90% conﬁdence intervals, except for
the change in suicidality which was lower than the comparable benchmark. The short-term changes were
retained at the three-month follow-up, except for family functioning (signiﬁcant reduction) and
suicidality (signiﬁcant improvement). For participants in clinical ranges pre-program, there was a large,
statistically signiﬁcant reduction in depressive symptomology, and large to very large, statistically
signiﬁcant improvements in behavioural and emotional functioning. These changes were retained at the
three-month follow-up. These ﬁndings indicate that WAT is as effective as traditional psychotherapy
techniques for clinically symptomatic people. Future research utilising a comparison or wait-list control
group, multiple sources of data, and a larger sample, could help to qualify and extend these ﬁndings.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Engagement and treatment of adolescents is a key challenge for
mental health clinicians. Mental health disorders affect a greater
proportion of young people than other age groups (Department of
Health and Ageing, 2013; World Health Organization, 2001), with
26% of 16–24 years old in Australia experiencing a personal mental
illness in the previous 12 months (Australia Bureau of Statistics
[ABS], 2007). Teenagers are susceptible to vulnerabilities arising
from social and cultural changes, including unstructured home
environments, growth in single-parent families, and media
saturated with sex, violence, and pleasure-seeking (Barrett &
Ollendick, 2004; Dowd, Singer, & Wilson, 2006; Villani, 2001).
Adolescents face a myriad of other challenges including learning* Corresponding author.
E-mail addresses: daniel@danielbowen.com.au (D.J. Bowen),
james.neill@canberra.edu.au (J.T. Neill), simon@neopsychology.com.au
(S.J.R. Crisp).
http://dx.doi.org/10.1016/j.evalprogplan.2016.05.005
0149-7189/ã 2016 The Authors. Published by Elsevier Ltd. This is an open access articlproblems, disengagement from education, family issues, home-
lessness, delinquency, substance abuse, and unemployment
(Perkins & Borden, 2003).
There are a wide range of treatment options which aim to
minimise the duration, severity, and recurrence of mental
disorders or, at least, to maximise the duration between episodes
(Mrazek & Haggerty, 1994). Meta-analytic reviews of psychother-
apeutic treatments for youth have found a range of short-term
effects including:
 psychotherapy for psychopathology (0.34; Weisz, McCarty, &
Valeri, 2006)
 cognitive behavioural therapy for anxiety (0.98; James, James,
Cowdrey, Soler, & Choke, 2013), depression (0.53; Klein, Jacobs, &
Reinecke, 2007), anger (0.67; Sukhodolsky, Kassinove, & Gor-
man, 2004), violent behaviour (0.09; Özabacı, 2011), antisocial
behaviour (0.48; Bennett & Gibbons, 2000), and criminal
offending (0.84; Landenberger & Lipsey, 2005); pharmacothera-
py for depression (0.19; Michael & Crowley, 2002) and anxiety
(0.69; Ipser, Stein, Hawkridge, & Hoppe, 2010)e under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
50 D.J. Bowen et al. / Evaluation and Program Planning 58 (2016) 49–59 multi-systemic therapy for antisocial behaviour and psychiatric
symptoms (0.55; Curtis, Ronan, & Borduin, 2004)
 rational emotive therapy for anxiety (0.48), disruptive behav-
iours (1.15), and self-concept (0.38; Gonzalez et al., 2004)
 family-based crime prevention programs for offending outcomes
(0.22), delinquency outcomes (0.32), and antisocial behaviour
outcomes (0.20; Farrington & Welsh, 2003)
 residential treatment programs for internalising problem
behaviour (0.45) and externalising problem behaviour (0.60;
Knorth, Harder, Zandberg, & Kendrick, 2008)
 art therapy for anxiety (0.49; Campbell, 2010) and music therapy
for mental illness (0.53; Gitman, 2009) and psychopathology
(0.61; Gold, Voracek, & Wigram, 2004).
Although there are a wide range of treatment options, most
interventions for teenagers are based on approaches which were
originally developed for adults (Crisp, 1997; Rutter et al., 2008).
However, adolescents’ needs differ substantially from adults’
needs (Rutter & Taylor, 2005). Teenagers who have mental health
issues are often hesitant to seek help and can be difﬁcult to engage
in traditional treatment modalities (Rickwood, Deane, & Wilson,
2007). Therapeutic approaches for teenagers should be developed
with an understanding of adolescent developmental needs in order
to address mental health problems in a way that decreases stigma
and promotes growth in fundamental domains of competency and
performance, responsibility, judgement, social orientation, moti-
vation, and identity (Crisp, 2014). Teenagers can beneﬁt from
modulated exposure to risk, stress, and precipitants of mental
health problems, thereby increasing resiliency and developing
protective strategies against future problems (Crisp, 1997; Rutter
et al., 2008). Adventure therapy is one such option to address at-
risk teenagers’ mental health problems (Schell, Cotton, &
Luxmoore, 2012; Tucker, Javorski, Tracy, & Beale, 2012).
1.1. Adventure therapy
Adventure therapy uses experiential learning activities in
outdoor environments for assessment and intervention at an
individual and group level, in order to effect psychological and/or
behavioural therapeutic change (Gass, Gillis, & Russell, 2012;
Norton, Carpenter, & Pryor, 2015). Adventure therapy utilises an
eclectic therapeutic approach, drawing on aspects of cognitive-
behavioural, systemic, existential, psychodynamic, and occupa-
tional therapy (Association for Experiential Education, 2012).
Adventure therapy may be used as a form of brief intervention or
embedded in a broader case management approach. Adventure
therapy empowers participants by providing fun and engaging
activities that involve real obstacles which, although often
appearing to be impossible to overcome, are attainable. Activities
are sequenced for success in order to provide participants with a
sense of self-efﬁcacy and mastery. Adventure therapy activities can
include problem-solving activities, ropes challenge courses,
outdoor adventure activities (such as rock climbing, abseiling,
rafting, caving, and bushwalking), and extended overnight
expeditions involving backpacking, canoeing and rafting, ski-
touring and/or snow camping. Meanings derived from participat-
ing in adventure therapy programs are intended to be incorporated
back into the participant’s individual and social world.
Although a relatively small ﬁeld, research to date has shown
adventure therapy to be effective in treating a range of behavioural
and mental health problems. A recent meta-analysis of 197 studies
of adventure therapy program outcomes (Bowen & Neill, 2013a)
found that adventure therapy is moderately effective in facilitating
positive short-term change in psychological, behavioural, emo-
tional, and interpersonal domains and that these changes appear to
be maintained in the longer term. The overall short-termadventure therapy standardised mean effect size (ES) was
moderately positive and statistically signiﬁcant (g = 0.47, p < 0.05),
and larger than for alternative treatment (0.14) and no treatment
(0.08) comparison groups. In this meta-analysis, adventure
therapy participants also reported small, positive, and not
statistically signiﬁcant change during the lead-up period (0.09)
and maintenance of the moderately positive short-term improve-
ments during the follow-up period (0.03). Of the eight major
outcome categories, clinical outcomes (e.g., anxiety, depression,
emotional stability, locus of control, resilience) had the highest ES
(0.50). The only signiﬁcant moderator was participant age. An ES of
approximately 0.5 is recommended as a benchmark for adventure
therapy programs, ESs between 0.3 and 0.5 are more typical of
programs for 9–17 year olds and ESs between 0.5 and 0.7 are more
typical of participants aged 18 years and over (see Bowen & Neill,
2013b for speciﬁc outcomes by age). Despite these promising
results, there is a lack of well-established adventure therapy
models that are supported by rigorous evaluations of their
effectiveness (Newes, 2000).
1.2. Wilderness adventure therapy
Wilderness Adventure Therapy1 (WAT) is a clinical psychology
treatment model developed by Simon Crisp (Crisp, 1997, 1998;
Crisp, Noblet, & Hinch, 2004). The WAT model is based on
principles of best practice service design and includes a systemic
framework and theoretical paradigm, client psychological assess-
ment, intake processes and treatment planning, group composi-
tion, psychological safety procedures, therapeutic group
procedures, monitoring of client outcomes, therapist skill training,
management of ethical issues, and research evaluation (Crisp,1997,
1998). The WAT model emphasises development of social-
emotional competencies and coping skills through group-based
adventure experiences that are facilitated by a psychologist. The
WAT model has undergone three phases of development (Crisp &
Hinch, 2004):
1. 1992–2000: WAT was designed as a multi-systemic, group
therapy intervention to treat adolescents with severe psycho-
logical, behavioural and psychiatric problems (Crisp & O’Don-
nell, 1998). It was developed in 1992 as a component of a clinical
adolescent day-program at the Austin Health, Child and
Adolescent Mental Health Service, Melbourne, Victoria,
Australia (CAMHS; Crisp, O’Donnell, Kingston, Poot, & Thomas,
2000). Between 1992 and 1996, 115 adolescents completed the
program (Kingston, Poot, & Thomas, 1997).
2. 2000–2001: A WAT program was provided as a “stand-alone”
out-patient treatment at the Barwon Health Adolescent Mental
Health Service, Geelong, Victoria, Australia (Crisp, 2003)
targeting a broad range of adolescent out-patients and their
parents who required more intensive out-patient treatment
than traditional approaches (Crisp et al., 2004). Six programs
during 2000 and 2001 were conducted, with 39 adolescents
completing the WAT treatment.
3. 2001–2003: WAT programs were implemented at the Inner East
Community Health Service, Melbourne, Victoria, Australia, to
work with local government high schools and community youth
and family agencies and to provide early intervention, preven-
tion and treat psychological, behavioural, and family-based
problems in adolescents before they required referral to a
clinical service (Crisp et al., 2004). Nine WAT programs were
implemented in this phase, with 36 adolescents completing the
WAT treatment: two early intervention programs involved Year
9 and 10 students at risk of educational non-completion or
school failure, one program was for families with one or more
adolescent child who had experienced substantial domestic
Table 1
Example WAT program structure.
Week Activity
4 Appraisal of referrals
3 Contacts parents
2 Parent and student information session
Student interviews
1 Teacher information session
1 Student introduction group
Teacher and parent introduction session
Day activity: Peak ascent
2 Student group
Student, teacher and parent session
Day activity: Cross-country skiing
3 Student group
Overnight expedition
4 Student group
Teacher and parent session
Day activity: Rock climbing and abseiling
5 Student group
Parent session
Day activity: Caving
6 Student group
Parent session
Day activity: Initiative course
7 Student group
Parent session
Day activity: Preparation for major expedition
8 Major Expedition: Coastal wilderness hike
9 Student group
Parent, student and teacher day: Rafting
10 Student group
Teacher and parent session
Graduation
11+ Handover to Teachers/Review
Reunion/Follow-up
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ability to function, one program was for female adolescents who
had experienced sexual assault, one program was for female
adolescents who had signiﬁcant body image issues or who were
in the early stages of an eating disorder, two programs were
conducted for families with adolescents in the early stages of
known or suspected substance abuse, and two programs
involved families with adolescents who had evidence of
signiﬁcant disruption to parent-adolescent attachment (Crisp
et al., 2004). Since 2003, other WAT programs have been
conducted in independent and government schools as commu-
nity and early-intervention programs.
The WAT intervention is a 10-week, manualised, part-time
program, which is typically facilitated by three WAT practitioners
for six to eight participants. The manual (Crisp et al., 2004)
includes protocol about how to implement the program for
different target groups, including early intervention at-risk clients,
community counselling where clients have already sought help
and WAT is part of on-going case management, and clinical
treatment that may be part of a multi-pronged approach within a
comprehensive range of clinical services.
The WAT program has four components (Crisp et al., 2004).
Intake (Week 1) includes screening, assessment, engagement,
orientation, and negotiation of client goals. Treatment (Weeks 2–9)
involves seven day-based adventure activities (e.g., bushwalking,
abseiling, cross country skiing, and white water rafting), a two-day
overnight training expedition, and a ﬁve-day expedition. Parents,
teachers, and support workers also participate in up to eight
weekly indoor adventurous problem-solving activities incorporat-
ed within group therapy sessions. Termination (Week 10) includes
a review of goals and unresolved needs/issues, identiﬁcation of
post-treatment goals and strategies, and enlisting of psycho-social
supports. Follow-up includes liaison with other agencies, group re-
union, and school or placement outreach follow-up. A sample
program structure is included in Table 1.
There have been several previous evaluations of WAT programs
(Crisp, 2003; Crisp & Aunger, 1998; Crisp & Hinch, 2004; Crisp &
Noblet, 2001; Crisp et al., 2004; Crisp & O'Donnell, 1998; Kingston
et al., 1997). An evaluation of 101 clients during Phase 1 found
statistically signiﬁcant improvements in self-reported difﬁculties
with social, attentional, and attitudinal problems, self-esteem, and
task leadership skills (Kingston et al., 1997). There were non-
signiﬁcant improvements in sociability, appearance, family, school,
emotions, parents, and crisis problems, achievement motivation,
emotional control, social competence, time management, with-
drawal, anxiety/depression, use of some coping strategies (e.g.,
self-blame, social action, ignoring, keeping problems secret, and
relaxation), social supports, physical recreation, and hard work
(Kingston et al., 1997). In addition, there were non-signiﬁcant
increases in not coping and somatic problems.
A case study of a 15-year-old girl (Susan) with psychological and
social problems, who completed WAT during Phase 1, was provided
by Crisp and Aunger (1998). Upon program completion, Susan
showed increased self-conﬁdence, personal insight, assertiveness,
sociality, and clarity of future plans. At the two-week follow-up,
Susan had returned to mainstream schooling with perfect
attendance and psychometric evaluation showed an increase in
coping skills, a reduction in reported emotional problems, and a
slight increase in self-esteem. At the six-month follow-up, Susan
was continuing to attend school full-time and was involved in a
range of extra-curricular activities. Crisp and O’Donnell (1998)
presented three other case vignettes of participants who complet-
ed WAT programs. Reported outcomes included an increased sense
of hope, perseverance, problem-solving, self-sufﬁciency, willing-
ness to access support, and returning to school.An evaluation of WAT during Phase 1 (n = 75) found that post-
treatment levels of symptoms were reduced but the differences
were not statistically signiﬁcant. However, at a ﬁve-year follow-up
mental health symptoms and the frequency of non-productive
coping had signiﬁcantly reduced.
Outcomes for 36 WAT Phase 2 participants were evaluated by
Crisp and Hinch (2004). Overall results indicated a statistically and
clinically signiﬁcant reduction in mental illness symptoms (from
clinical levels to non-clinical levels following the WAT interven-
tion) which remained at three-month and two-year follow-ups.
Furthermore, there were statistically signiﬁcant improvements in
general and social self-esteem following treatment, with non-
signiﬁcant improvements in life-threatening attitudes, productive
and non-productive coping, social competence, school functioning,
psychological resilience, and family relationships.
Crisp and Noblet (2001) evaluated a Phase 3 WAT program for
eight clients who were at risk of school failure and experiencing
mental health problems. Results indicated clinically signiﬁcant
improvements in mental health, behaviour problems, and life-
threatening attitudes (i.e., future high-risk behaviour). Non-
signiﬁcant improvements were evident for expectation of receiv-
ing help and increased connectedness to, and trust in, peers,
communication, and overall functioning.
Program evaluation results for 36 clients from six WAT Phase 3
programs who were identiﬁed as showing risk factors including
school failure, poor body image and eating problems, substance
abuse, being victims of sexual abuse or assault, and/or family
dysfunction indicated a statistically and clinically signiﬁcant
reduction in mental illness symptoms which remained at
follow-up (3 months later; Crisp et al., 2004). Furthermore, there
were statistically signiﬁcant improvements in general and social
self-esteem following treatment, and school self-esteem showed a
delayed statistically signiﬁcant improvement at follow-up. There
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threatening attitudes, productive and non-productive coping,
social competence and school functioning, psychological resil-
ience, and family relationships.
Therapeutic programs for youth that utilise innovative and non-
traditional approaches often do so in isolation and with limited
knowledge about how to maximise their effect. A critical task for
adventure therapy program developers, and for advancing the
adventure therapy movement as a whole, is the use of high quality
program design along with research and evaluation. Although WAT
Phase 1–3 programs have been evaluated, the data should be
independently analysed by non-program staff, expressed as effect
sizes and benchmarked against adventure therapy meta-analytic
ﬁndings, and formally peer-reviewed. Due to the varying target
groups and level of symptom severity of WAT Phase 1 and Phase 3
programs, as well as the small samples sizes, it was impractical to
include data from these programs. Therefore, this study builds on
previous WAT research by evaluating the participant outcomes for
WAT Phase 2 programs using standardised mean effect sizes and
compares the outcomes to adventure therapy meta-analytic
ﬁndings. It was hypothesised that the WAT treatment would be
associated with statistically signiﬁcant short-term improvements
in psychological and behavioural symptomatology, that these
changes would be maintained at a three month follow-up, and that
the amount of change would be at least equivalent to comparable
adventure therapy benchmarks.
2. Method
2.1. Participants
There were 36 participants (21 females and 15 males) who were
out-patients of a regional state-based adolescent mental health
service in Victoria, Australia (Barwon Health) who required more
intensive out-patient treatment than traditional approaches.
Participants were aged between 12 and 18 years (M = 14.6;
SD = 1.6). Participants completed one of six standardised WAT
interventions during 2000 and 2001. The only other treatment
option of equal or greater intensity was admission to a psychiatric
in-patient ward (Crisp & Hinch, 2004).
The most common primary reason for referral to the program
was conduct/behaviour (29%), followed by depression (21%),
anxiety (14%), identity/self-esteem (14%), relationship problems
(14%), and psychosis (8%). On average, there were six additional
presenting problems per participant, including low-esteem (71%),
poor relationships with adults (65%), family (65%) and peers (47%),
anxiety (41%), family mental illness (41%), and depression (35%).
2.2. Materials
Six self-report questionnaires, consisting of 226 closed-ended
items, were completed by participants on up to three occasions:
pre-program (Time 1), post-program (Time 2), and at a three-
month follow-up (Time 3).
2.2.1. Resilience Questionnaire
The Resilience Questionnaire (RQ) is designed to measure
psychological resilience (Crisp, 2001). It consists of 14 items. Four
items are rated on a dichotomous scale (True (1 point) or False (2
points); e.g., “I can change things in my life if I really try.”). The
other 10 items are measured on a seven-point Likert scale. For
example, the item “How close, or connected to any person your
own age do you feel?” is rated from 1 (Very Close/Connected) to 7
(Not Very Close/Connected). A total score was calculated by adding
the scores from the true-false and Likert scale items, ranging from14 to 78. Higher scores signify lower resilience. For the current
study, the internal consistency was strong (Cronbach’s a = 0.83).
2.2.2. Beck Depression Inventory-II
The Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown,
1996) assesses severity of depressive symptomology. There are 21
items measured using a four point ordinal scale (0 = I Do Not Feel
Sad; 1 = I Feel Sad Much of the Time; 2 = I Am Sad All the Time; 3 = I
Am So Sad or Unhappy That I Can’t Stand It). Items are summed to
form a total score that ranges from 0 to 63, with higher scores
indicating greater depressive symptomology (Minimal = 0–13;
Mild = 14–19; Moderate = 20–28; Severe = 29–63). The BDI-II has
high internal consistency amongst a variety of populations
(a = 0.91–0.93) and the one-week test-retest reliability is strong
(r = 0.93; Antony & Barlow, 2010). Convergent validity is supported
by signiﬁcant correlations with other indices of depression,
including the Beck Depression Inventory (0.93), the Hamilton
Rating Scale for Depression (0.71), and the 7-item Depression
subscale of the Depression Anxiety Stress Scales (0.76; Antony &
Barlow, 2010).
2.2.3. Youth Self-Report
The Youth Self-Report (YSR; Achenbach, 1991) assesses
participants’ level of behavioural and emotional functioning.
There are 112 items measured on a three-point ordinal scale
(0 = Not True, 1 = Somewhat or Sometimes True, 2 = Very True or
Often True). The YSR is comprised of eight core syndrome scales:
Withdrawn, Somatic Complaints, Anxious/Depressed, Social Prob-
lems, Thought Problems, Attention Problems, Aggressive Behav-
iour, and Delinquent Behaviour. The YSR also includes two higher
order scales: Internalising (Withdrawn, Somatic Complaints,
Anxious/Depressed) and Externalising (Aggressive Behaviour,
Delinquent Behaviour) problems, and a Total score (includes all
8 core syndrome scales; Achenbach & Rescorla, 2001). Raw scores
are converted to a T-score, with higher scores reﬂecting poorer
behavioural and emotional functioning. T-scores 67 or higher for
the syndrome scales and 60 or higher for the higher order scales
are clinically signiﬁcant (Achenbach,1991). The YSR core syndrome
scales have reasonable internal consistency amongst a variety of
populations (a = 0.71–0.89). One-week test-retest coefﬁcients are
generally good, with all scales being above 0.70, except for
Withdrawn/Depressed. Seven-month test-retest correlations are
generally in the 0.50 range (Achenbach & Rescorla, 2001).
2.2.4. Coopersmith Self Esteem Inventory
The Coopersmith Self Esteem Inventory (CSEI; Coopersmith,
1981) measures self-esteem. The CSEI includes 50 items which
represent four subscales: General (26 items; e.g., “I am pretty sure
of myself”), Social (8 items; e.g., “I am easy to like”), Home/Parents
(8 items; e.g., “My family understands me”), and School/Academic
(8 items; e.g., “I am proud of my school work”). For each item, the
dichotomous response scale is “Unlike Me” (0 points) or “Like Me”
(1 point). The sum of all items provides an estimate of global self-
esteem, ranging from 0 to 50. Higher scores signify greater self-
esteem. The CSEI has reasonable internal consistency amongst a
variety of populations (KR-20 = 0.80–0.92); Coopersmith, 1981).
2.2.5. CORE Family Functioning Questionnaire
The CORE Family Functioning Questionnaire (Author Unknown,
2001) is designed to assess family functioning. The CORE FFQ
consists of ﬁve items measured on a ﬁve-point Likert scale ranging
from 1 (Very Well) to 5 (Poor). A sample item is “How well has your
family communicated together over the past month?”. Total scores
can range from 5 to 25, with higher scores reﬂecting poorer family
functioning. For the current study, the internal consistency was
0.92.
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The Life Attitudes Schedule – Short Form (LAS-SF; Rohde,
Lewinsohn, Seeley, & Langhinrichsen-Rohling, 1996) measures
adolescents’ suicide-proneness. The dichotomous response
options for the 24 items (e.g., “I avoid unnecessary risks”) were
False (0) or True (1). The 12 positively worded items were reverse-
scored and summed with the 12 negatively worded items to create
a total score that can range from 0 to 24, with higher scores
indicating greater risk of suicidality. The LAS-SF has reasonable
internal consistency (KR-20 = 0.80), and the 30-day test-retest
reliability was moderate (0.73; Rohde et al., 2003).
2.3. Procedure
The questionnaires were administered in a standardised
manner on a one-to-one basis prior to the ﬁrst program session
(Time 1), following the ﬁnal program session (Time 2), and three
months after the completion of the program (Time 3). Additional
assistance and/or verbal administration were provided when
required (e.g., poor attention or literacy skills). On average, it took
45–60 min for participants to complete the six questionnaires on
each occasion.
2.4. Analysis
Thirty six participants provided pre-program (Time 1; T1), post-
program (Time 2; T2), and follow-up (Time 3; T3) data. However,
24% of the data values were missing due to participant non-
completion of some of the survey questions, with lower comple-
tion rates for measures collected in the latter half of the test
battery. Thus, multiple imputation was used to replace the missing
data. Multiple imputation uses a regression-based procedure to
generate multiple copies of the data set, each of which contains
different estimates of the missing values (Enders, 2010). Based on
Graham’s (2012) recommendation, the Markov-Chain Monte Carlo
(MCMC) method in SPSS 22 was used to generate 40 imputed data
sets, with 50 iterations of MCMC between each imputation.
Methodologists regard multiple imputation as a “state of the art”
missing data technique because it improves the accuracy and the
power of the analyses relative to other missing data handling
methods (Schafer & Graham, 2002).
Scale means were reﬂected, where necessary, so that increased
scores over time signiﬁed improvement. Short-term (T1–T2) and
follow-up (T2–T3) changes were investigated using descriptive
statistics and standardised mean ESs (Hedges’ g). A commonly
referred to rule of thumb for interpreting standardised mean ESs isTable 2
Descriptive statistics for T1-T3 questionnaire totals and overall, with effect sizes, 90% c
Constructs T1 M (SD) T2 M (SD) T3 M (SD) 
Behavioural & Emotional Functioning 36.51 (7.92) 39.21 (7.09) 39.44 (7.14) 
Depression 42.33 (15.26) 48.63 (12.04) 48.61 (11.30) 
Family Functioning 13.25 (4.19) 13.75 (4.01) 11.48 (3.85) 
Resilience 33.53 (12.09) 38.94 (9.80) 36.00 (9.51) 
Self-Esteem 48.58 (20.71) 53.51 (17.76) 54.47 (15.50) 
Suicidal-Proneness 15.85 (3.95) 15.57 (5.28) 17.52 (3.77) 
Overall 
Note: ST = Short-Term; FU = Follow-Up; ES = Effect Size (Hedges g); CI = Conﬁdence Inter
indicates ES is statistically signiﬁcant. An increase in mean over time signiﬁes improve0.20 (small), 0.50 (medium), and 0.80 (large; Cohen, 1988). Ninety
percent conﬁdence intervals (CIs) for ESs are also reported. If an ES
CI excludes zero, then the ES is statistically signiﬁcant (Ellis, 2010).
However, ES CIs should be interpreted with caution as power for a
two-tailed test was estimated to be 47%, based on the overall
average ES (0.26), a sample size of 36, and a 90% conﬁdence level.
ESs are also expressed as estimated percentages of participants
who improved, using the Binomial Effect Size Display (BESD;
Randolph & Edmondson, 2005) and Cohen’s (1988) U3. Using the
BESD, an effect size of 0.2 is equivalent to a 10% increase in the
outcome of interest, whilst an effect size of 0.4 is equivalent to a
20% increase in the outcome of interest. Using Cohen’s U3, an effect
size of 0.2 is equivalent to 58% of participants who received
treatment being better off than an equivalent group who did not
participate, whilst an effect size of 0.4 means that 66% of
participants who received treatment are likely to be better off
than an equivalent group who did not participate.
Participants were an out-patient group of adolescents with
diverse reasons for referral, thus it was important to consider the
outcomes in clinical terms, that is, the presence or absence of
pathology (Kazdin, 1999). Additional analyses (Glasser, 2014) were
conducted for the two questionnaires (BDI-II and YSR) in which
clinical cut-offs were available. Short-term and follow-up changes
for participants who reported clinical and non-clinical levels of
depression and behavioural and emotional dysfunction pre-
program were investigated using descriptive statistics and stand-
ardised mean ESs. Short-term and follow-up descriptive statistics
and ESs were also calculated for the most severe symptom for each
participant, as indicated by the most elevated subscale on the YSR
for each participant before treatment.
3. Results
3.1. Overall
Descriptive statistics for participant responses to each of the six
questionnaires at T1–T3 are presented in Tables 2–4 , along with
standardised mean ESs with CIs for short-term changes (T1–T2)
and during the follow-up period (T2–T3). Overall and question-
naire total results are shown in Table 2. Subscale results for the
CSEI (self-esteem) are shown in Table 3 and the YSR (behavioural
and emotional functioning) subscale results for participants with
clinical and non-clinical range pre-program scores are shown in
Table 4. Tables 2 and 3 also show short-term ES adventure therapy
benchmarks for 10–17 years olds from Bowen and Neill’s (2013b)
meta-analysis. Statistically signiﬁcant short-term ESs and meta-onﬁdence intervals for WAT participants, and comparative benchmarks (N = 36).
STES STCI FUES FUCI ST BMES ST BMCI BM Category
.36 .03: .75 .03 .36: .42 .46* .37: .54 Clinical
.46* .07: .85 .00 .39: .39 .46* .37: .54 Clinical
.12 .27: .51 .58* .97: .18 .31* .14: .48 Family Development
.49* .10: .89 .30 .69: .09 .46* .37: .54 Clinical
.26 .13: .64 .06 .33: .45 .41* .34: .47 Self-Concept
.06 .45: .33 .43* .03: .82 .46* .37: .54 Clinical
.26* .12: .41 .06 .28: .16 .44* .38: .50 Total
val; BM = Benchmark (10–17 year olds; obtained from Bowen and Neill, 2013b). *
ment.
Table 3
Descriptive statistics for T1, T2, and T3 self-esteem (CSEI) subscales, with effect sizes, 90% conﬁdence intervals for WAT participants, and comparative benchmarks (N = 36).
Self-Esteem Subscales T1 M (SD) T2 M (SD) T3 M (SD) STES STCI FUES FUCI ST BMES ST BMCI BM Used
General 12.61 (6.07) 13.80 (5.14) 15.70 (4.47) .21 .18: .60 .39* .00: .79 .41* .34: .47 Self-Concept
Home/Parents 3.50 (2.34) 4.29 (2.27) 3.79 (2.24) .34 .05: .73 .22 .61: .17 .31* .14: .48 Family Development
School/Academic 3.78 (1.95) 3.46 (1.66) 3.59 (1.52) .18 .57: .21 .08 .31: .47 .44* .34: .54 Academic Perception
Social 4.42 (6.07) 5.18 (1.93) 5.13(1.75) .40* .01: .79 .03 .41: .36 .41* .32: .49 Social Development
Total 48.58(20.71) 53.51(17.76) 54.47(15.50) .26 .13: .64 .06 .33: .45 .41* .34: .47 Self-Concept
* indicates ES is statistically signiﬁcant.
Table 4
Descriptive statistics for T1, T2, and T3 behavioural and emotional (YSR) subscales, with effect sizes, and 90% conﬁdence intervals for WAT participants in the clinical and non-
clinical range before treatment.
Behavioural & Emotional Subscales N T1 M (SD) T2 M (SD) T3 M (SD) STES STCI FUES FUCI
Clinical Range Participants
Internalising 26 31.69# (6.37) 37.46 (7.64) 38.34 (7.45) 0.82* 0.35: 1.30 .12 0.34: 0.57
Somatic Complaints 11 23.96# (9.45) 35.51 (7.46) 34.81 (10.76) 1.36* 0.58: 2.13 .08 0.78: 0.63
Anxious/Depressed 23 25.00# (8.62) 32.86 (10.13) 35.25 (9.88) 0.84* 0.33: 1.34 .24 0.25: 0.73
Withdrawn 7 29.31# (3.02) 34.82 (12.87) 37.87 (7.22) 0.59 0.31: 1.49 .29 0.59: 1.18
Externalising 21 30.13# (7.60) 33.41# (8.17) 34.44 (8.88) 0.42 0.10: 0.93 .12 0.39: 0.63
Social Problems 18 28.10# (5.09) 34.09 (11.03) 36.22 (7.61) 0.70* 0.13: 1.26 .22 0.33: 0.77
Attention Problems 16 22.50# (9.92) 29.95# (14.92) 32.29# (8.90) 0.59 0.01: 1.18 .19 0.39: 0.77
Thought Problems 8 27.37# (8.89) 40.19 (5.57) 34.06 (14.42) 1.73* 0.76: 2.69 .56 1.40: 0.28
Aggressive Behaviour 10 24.64# (7.94) 31.51# (8.77) 29.77# (10.27) 0.82* 0.06: 1.59 .18 0.92: 0.55
Delinquent Behaviour 15 24.86# (7.22) 28.00# (9.06) 32.79# (10.79) 0.38 0.22: 0.99 .48 0.13: 1.09
Total 26 32.18# (5.80) 36.54 (6.56) 36.66 (6.74) 0.70* 0.23: 1.17 .02 0.44: 0.47
Non-Clinical Range Participants
Internalising 10 45.81 (3.21) 44.32 (4.87) 44.42 (4.00) 0.36 1.10: 0.38 .02 0.71: 0.76
Somatic Complaints 25 42.78 (5.17) 43.66 (6.01) 42.21 (5.73) 0.16 0.31: 0.62 .25 0.71: 0.22
Anxious/Depressed 13 45.07 (4.35) 44.10 (6.33) 44.01 (5.86) 0.18 0.83: 0.47 .01 0.66: 0.63
Withdrawn 29 41.68 (5.60) 42.35 (5.64) 43.57 (4.93) 0.12 0.31: 0.55 .23 0.20: 0.66
Externalising 15 46.03 (2.64) 44.68 (5.41) 44.00 (5.13) 0.32 0.92: 0.29 .13 0.73: 0.47
Social Problems 18 41.52 (6.12) 41.87 (8.07) 40.22 (8.76) 0.05 0.50: 0.60 .20 0.75: 0.35
Attention Problems 20 42.74 (4.57) 42.30 (6.36) 41.81 (6.96) 0.08 0.60: 0.44 .07 0.59: 0.45
Thought Problems 28 46.03 (5.13) 45.04 (5.93) 44.65 (6.01) 0.18 0.62: 0.26 .07 0.51: 0.37
Aggressive Behaviour 26 43.68 (5.46) 43.07 (7.02) 42.74 (6.38) 0.10 0.55: 0.36 .05 0.51: 0.41
Delinquent Behaviour 21 42.73 (4.57) 42.53 (6.36) 41.36 (6.96) 0.04 0.54: 0.47 .18 0.68: 0.33
Total 10 45.17 (2.91) 44.55 (4.67) 45.01 (3.97) 0.16 0.90: 0.58 .11 0.63: 0.84
Note: # indicates mean in the clinical range (reﬂected T-score clinical range = 0– 33). * indicates ES is statistically signiﬁcant.
Fig. 1. Statistically signiﬁcant short-term effect sizes and meta-analytic benchmarks for all participants and clinical range participants.
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participants are presented in Fig. 1.
The overall short-term ES for WAT program participants was
small, positive, and statistically signiﬁcant (0.26), representing a
13% overall improvement and is akin to 60% of participants
reporting improvements at the end of the program. The total short-
term ESs were statistically signiﬁcant for two of the questionnaires
(p < 0.10; RQ (resilience) ES = 0.49; BDI-II (depression) ES = 0.46)
and non-signiﬁcant for the other four questionnaires (p > 0.10; YSR
(behavioural and emotional functioning) ES = 0.36; CSEI (self-
esteem) ES = 0.20; CORE FFQ (family functioning) ES = 0.12; LAS-SF
(Suicidal-proneness) ES = 0.06; see Table 2).
The overall follow-up period (T2–T3) ES was very small,
negative, and not statistically signiﬁcant (0.06), representing a 3%
loss, and thus indicating overall retention of the short-term gains.
During the follow-up period, the total ES was statistically
signiﬁcant for one questionnaire (suicidal-proneness ES = 0.43)
and not statistically signiﬁcant for the other ﬁve measures (family
functioning ES = 0.58; resilience ES = 0.30, depression ES = 0.00,
behavioural and emotional functioning ES = 0.03, and self-esteem
ES = 0.06; see Table 2). The follow-up result for suicide-proneness
represents a 21% improvement and is akin to 67% of participants
reporting improvements in suicidality during the three-month
follow-up period.
3.2. Self-esteem
The results for the CSEI (self-esteem) subscales are reported in
Table 3. The short-term ESs were statistically signiﬁcant for one of
the subscales (Social ES = 0.40) and non-signiﬁcant for the other
three subscales (Home/Parents ES = 0.34; General ES = 0.21;
School/Academic ES = 0.18). During the follow-up period, the
ES for one of the subscales was statistically signiﬁcant (General
ES = 0.39), while the ES for the other three subscales was non-
signiﬁcant (School/Academic ES = 0.08; Social ES = 0.03; Home/
Parents ES = 0.22).
3.3. Depression
3.3.1. Clinical participants
Twenty-three participants reported clinical levels of depressive
symptoms pre-program, as measured by the BDI-II (T1 M = 34.03,
SD = 12.84; Severe range; see Fig. 2). For these participants, the
short-term change was large, positive, and statistically signiﬁcant
(ES = 0.80; 37% change; CI = 0.30:1.31; T2 M = 44.19, SD = 12.45; Mild
range). Change during the follow-up period was very small,
positive, and not statistically signiﬁcant (0.03; 1% change;
CI = 0.46:0.51; T3 M = 44.51, SD = 11.31; Mild range), indicatingFig. 2. Pre-program, post-program and 3-month follow-up depressive symptom
(BDI-II) means for participants in the clinical (N = 23) and non-clinical (N = 13) range
before treatment.retention of the short-term gains. The average short-term effect is
akin to 79% of clinical range participants reporting improvements
in mental health at the end of the program and at follow-up.
3.3.2. Non-clinical participants
Thirteen participants reported non-clinical levels of depressive
symptoms pre-program (T1 M = 57.00, SD = 3.99; Minimal range;
see Fig. 2). For these participants, the short-term ES was small,
positive, and not statistically signiﬁcant (ES = 0.26; 13% change;
CI = 0.39:0.91; T2 M = 58.1; Minimal range). During the follow-up
period for these participants, the ES was small, positive, and not
statistically signiﬁcant (ES = 0.22; 11% change; CI = 0.42:0.87;
T3 M = 59.1; Minimal range). Thus, for these non-clinical partic-
ipants, there was small, positive and non-signiﬁcant change from
pre-program to post-program, and from post-program to follow-
up.
3.4. Behavioural and emotional functioning
3.4.1. Clinical participants: total
Twenty six participants reported clinical levels of behavioural
and emotional dysfunction pre-program, as measured by the YSR
(see Table 4). For these participants, the overall short-term ES was
large, positive, and statistically signiﬁcant (0.70; 33% change). The
follow-up period ES was very small, positive, and not statistically
signiﬁcant (0.02; 1% change), indicating retention of the short-
term gains. The average overall short-term effect is akin to 76% of
clinical range participants reporting improvements in mental
health at the end of the program and at follow-up.
3.4.2. Non-clinical participants: total
Ten participants reported non-clinical levels of overall behav-
ioural and emotional dysfunction pre-program (see Table 4). For
these participants, the overall short-term ES was small, negative,
and not statistically signiﬁcant (0.16; 8% change). During the
follow-up period, the ES was small, positive, and not statistically
signiﬁcant (0.11; 4% change). Thus, for these non-clinical partic-
ipants, there was minimal change from pre-program to post-
program and from post-program to follow-up.
3.4.3. Clinical participants: sub-scales
The short-term ES for the 26 participants who reported clinical
levels of Internalising problems was large, positive, and statisti-
cally signiﬁcant (0.82; 38% change) and for the 21 participants who
reported clinical levels of Externalising problems, the ES was
moderate, positive, and not statistically signiﬁcant (0.42; 21%
change). During the follow-up period, the change in Internalising
and Externalising problems was very small, positive, and not
statistically signiﬁcant (ES = 0.12; 6% change).
Analyses of changes for participants with clinical-range pre-
program scores for each of the YSR subscales found large to very
large statistically signiﬁcant short-term ESs for ﬁve subscales
(Thought problems, ES = 1.73, n = 8; Somatic Complaints ES = 1.36,
n = 11; Anxious/Depressed ES = 0.84, n = 23; Aggressive Behaviour
ES = 0.82, n = 10; Social Problems ES = 0.70, n = 18) and three of the
subscales were non-signiﬁcant (Attention Problems ES = 0.59,
n = 16; Withdrawn ES = 0.59, n = 7; Delinquent Behaviour ES = 0.38,
n = 15; see Fig.1). The YSR subscale ESs during the follow-up period
were non-signiﬁcant and ranged from moderate and positive
(Delinquent Behaviour, ES = 0.48; 23% change; n = 16) to moderate
and negative (Thought Problems, ES = 0.56; 27% change; n = 8).
Thus, there was clinically signiﬁcant change for those within the
clinical ranges for ﬁve out of eight YSR subscales (internalising
problems, social problems, aggressive behaviour, anxiety/depres-
sion, somatic complaints and thought problems), which were
retained at follow-up.
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The short-term ES for participants who reported non-clinical
levels of Internalising and/or Externalising problems was moder-
ate, negative, and not statistically signiﬁcant (0.36; 18% change;
n = 10 and ES = 0.32; 16% change; n = 15 respectively). During the
follow-up period, the change in Internalising problems was very
small, positive, and not statistically signiﬁcant (ES = 0.02; 1%
change), whilst the change in Externalising problems was small,
negative, and not statistically signiﬁcant (ES = 0.13, a 1% change).
The eight core syndrome subscale short-term ESs were non-
signiﬁcant and ranged from small and positive (Somatic Com-
plaints, ES = 0.16; 8% change; n = 25) to small and negative
(Anxious/Depressed and Thought Problems, ES = 0.18; 9% change;
n = 13 and 28 respectively). The eight core syndrome subscale ESs
during the follow-up period were non-signiﬁcant and ranged from
small and positive (Withdrawn, ES = 0.23; 11% change; n = 29) to
small and negative (Somatic Complaints, ES = 0.25; 12% change;
n = 25). Thus, for these non-clinical participants, there was minimal
change from pre-program to post-program and from post-program
to follow-up.
3.4.5. Severest symptoms
Short-term and follow-up ESs were also calculated for the most
severe symptom for each participant, as indicated by the most
elevated subscale on the YSR for each of the 36 participants before
treatment (T1 M = 24.58, SD = 12.34; N = 36; clinical range; see
Fig. 3). The short-term ES for the most severe symptoms was
moderate, positive, and statistically signiﬁcant (ES = 0.57; 27%
change; CI = 0.18:0.97; T2 M = 32.29, SD = 14.55; clinical range). The
follow-up ES was very small, negative, and not statistically
signiﬁcant (ES = 0.02; 1% change; CI = 0.40:0.37; T3 M = 32.06,
SD = 14.24; clinical range), indicating retention of the short-term
gains. The average short-term ES of 0.57 is akin to 72% of program
participants reporting short-term improvements in the most
problematic aspect of their behavioural and emotional functioning.
4. Discussion
This study examined the short- and longer-term changes in
WAT participants’ psychosocial, behavioural, and psychological
functioning. These changes are interpreted here in the context of
adventure therapy and psychotherapeutic meta-analytic outcome
research. Lessons learned and limitations of the present study are
also considered.Fig. 3. Pre-program, post-program and follow-up YSR means for the most severe
behavioural and emotional dysfunction for participants before treatment (N = 36).4.1. Efﬁcacy of WAT
4.1.1. Overall short-term effect
This study provides mixed evidence about the effectiveness of
WAT as a psychotherapeutic treatment. Overall, there was a small,
positive, statistically signiﬁcant short-term impact on the mea-
sured outcomes (ES = 0.26). This result is similar to meta-analytic
results for 10–17 year old adventure therapy participants (Bowen &
Neill, 2013b), but is lower than ﬁndings from psychotherapy
outcome research. There were moderate, statistically signiﬁcant,
short-term improvements in participants’ psychological resilience
and depression, moderate, non-statistically signiﬁcant improve-
ments in behavioural and emotional functioning, and small, non-
statistically signiﬁcant improvements in self-esteem and family
functioning. There was little to no evidence of short-term
improvements in suicidality. All the short-term effects were
within the adventure therapy age-based meta-analytic benchmark
CIs, except for suicidality which was lower than the comparable
benchmark.
4.1.2. Overall follow-up effect
The overall follow-up ES was very small, negative, and not
signiﬁcant (ES = 0.06), indicating no substantial change during
the three-month follow-up period. This ﬁnding is consistent with
the very small, positive, non-statistically signiﬁcant follow-up ES
for adventure therapy (ES = 0.03) reported by Bowen and Neill
(2013a). The follow-up effect was not signiﬁcant for each of
questionnaire totals and subscales, with the exception of family
functioning, for which participants reported reduced functioning,
and suicide-proneness, which decreased. As family functioning can
be a signiﬁcant factor in the development and maintenance of
mental health disorders as well as social and school functioning
(Greenberg & Lippold, 2013; Patel, Flisher, Hetrick, & McGorry,
2007), it may be an important consideration in the development of
future WAT interventions to use a multi-family group format and/
or explicitly aim to teach effective family functioning strategies as
an overall treatment goal. As adolescent suicide is a signiﬁcant
public health concern (Sakinofsky et al., 2007), the statistically
signiﬁcant reduction in suicidality at follow-up is noteworthy. The
delayed change in suicidality may reﬂect a process that begins with
improvements in resilience and levels of depressive symptoms
that take time to generalise to suicide-proneness. This ﬁnding may
also suggest that reductions in suicidality and self-harm risk may
take several months. Adventure therapy programs such as WAT
could also consider offering one or more follow-up "booster’"
session to help generalise and integrate changes.
4.1.3. Effect on self-esteem
The short-term ES for Social self-esteem was moderate,
positive, and statistically signiﬁcant. Self-esteem subscale effects
for Social, Home/Parents, and General self-esteem were moder-
ately positive and within the expected age-based benchmark CI,
whereas the School/Academic effect was lower than expected. The
follow-up effect for each of the self-esteem subscales was not
signiﬁcant, with the exception of General self-esteem, for which
participants reported a signiﬁcant increase. The delayed change in
General self-esteem may reﬂect a process that begins with
improvements in social self-esteem.
4.1.4. Effect on depression
The overall short-term effect on depression was small and not
signiﬁcant, however the short-term effect for the 23 participants
who reported clinical levels of depressive symptoms pre-program
was large, positive, and statistically signiﬁcant, and this was
retained in the longer-term. Consistent with a previous evaluation
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participants was in the Severe range, moved to the Mild range by
the end of the program, and remained in the Mild range at the
three-month follow-up. There were no statistically signiﬁcant
short- or longer-term changes in depressive symptoms for the 13
participants who were not in the clinical range pre-program. Thus,
it seems that clients with depressive symptoms respond well, with
clinically meaningful reductions in symptoms. Such magnitude of
beneﬁt appears comparable to the most efﬁcacious treatments
reported in the literature (Klein et al., 2007; Michael & Crowley,
2002; Singh & Reece, 2014).
4.1.5. Effect on behavioural and emotional functioning
The overall short-term effect for the 26 participants who
reported clinical levels of behavioural and emotional dysfunction
pre-program was large, positive, and statistically signiﬁcant, and
was retained in the longer-term. Short-term effects for participants
who reported clinical levels of symptoms were positive, large, and
statistically signiﬁcant for 6 out of the 10 of the YSR subscales
(Social Problems, Aggressive Behaviour, Internalising Problems,
Anxious/Depressed, Somatic Complaints, Thought Problems).
These short-term changes were retained at follow-up. At the
three-month follow-up, 7 out of the 10 subscale means had moved
out of the clinical range. This result is important as it shows that
participants experienced reduced symptoms that are clinically
meaningful. For the 10 participants who reported non-clinical
levels of behavioural and emotional dysfunction pre-program,
there were no statistically signiﬁcant short- or longer-term
changes. All participants who were in the non-clinical range
pre-program remained in the non-clinical range for all YSR
subscales at the three-month follow-up.
The short-term WAT program effect on the most severe area of
participants’ symptoms was moderate, positive, and statistically
signiﬁcant and this change was maintained in the longer-term.
This result is important as it shows that in the area of greatest need,
clients experienced reduced symptoms. Although the mean T-score
of the most severe area of participants’ symptoms improved from
pre-program to the three-month follow-up, it remained in the
clinical range.
4.1.6. Summary of effects
Overall, these ﬁndings suggest that WAT participants experi-
enced a small, positive, statistically signiﬁcant overall improve-
ment in psychosocial functioning, with moderate, positive,
statistically signiﬁcant improvements in psychological resilience,
depression, and social self-esteem, and non-signiﬁcant improve-
ments in psychological, emotional, and behavioural functioning.
For the most part, the changes appear to have been retained at a
three-month follow-up. Although there was no short-term change
in suicidality, there was a moderate, statistically signiﬁcant longer-
term reduction in suicidality.
As there were diverse presenting issues, additional analyses
focused on participants who were in clinical ranges pre-program.
These analyses revealed large, positive, and statistically signiﬁcant
improvements in depressive symptomology and behavioural and
emotional functioning which were retained at a three-month
follow-up. In comparison, participants who were in the non-
clinical range pre-program, for the most part, experienced
relatively little short- or longer-term change.
4.2. Lessons learned
The WAT program is an experiential, adventure activity-based
approach to prevention, early intervention, and treatment for
adolescents, delivered within a case management framework.
Adventure therapy is not a panacea, but it can be useful in a varietyof settings and for a broad spectrum of clients. Overall, there were
statistically signiﬁcant short-term improvements in resilience,
social self-esteem and depression, and statistically signiﬁcant
improvements in the follow-up period for suicidality and general
self-esteem. These results suggest that WAT can help adolescents
to improve dysfunctional beliefs and attitudes, maladaptive
behaviours, coping strategies, inadequate problem-solving meth-
ods, and to develop greater resilience to overcome risks and avoid
negative outcomes in the future. However, the short-term change
for academic self-esteem, when compared to the relevant meta-
analytic benchmark, was lower than expected. Thus, the WAT
program may be less well suited to improving adolescents’
academic self-esteem.
Importantly, participants in clinical ranges pre-program,
reported clinically and statistically signiﬁcant improvements in
depression, internalising and externalising problems, somatic
complaints, anxiety, depression, withdrawal, social problems,
thought problems and overall behavioural, and emotional func-
tioning. These results suggest that WAT may be especially well
suited to treating participants with clinical psychological symp-
toms. However, given the notable differences in results between
participants in clinical and non-clinical ranges, it may be that WAT
is an appropriate treatment modality for participants with clinical
symptoms, but less well suited to prevention and early interven-
tion. Alternatively, it may be that the evaluation methodology was
not sufﬁciently targeted at indicators of efﬁcacy with regard to
prevention and early intervention.
The statistically signiﬁcant improvements in suicidality and
general self-esteem during the follow-up period may reﬂect a
process that begins with improvements in resilience, alleviation of
depressive symptoms, and enhanced social self-esteem but that
takes time to generalise to suicide proneness and general self-
esteem. Further research could investigate the reasons for, and
mechanisms of, these delayed changes, as well as effects
experienced by participants at even later post-program time-
points.
Despite the promise of adventure therapy and the WAT model,
more in-depth and rigorous program evaluation could be
considered. This could take the form of clinical trials of adventure
therapy programs tailored to homogenous client groups (e.g., of
depressed or conduct disordered adolescents) and use quasi- or
fully-experimental designs, including wait-list control groups or
cross-over designs with conventional treatments such as CBT. It
could also be helpful to investigate which components of
adventure therapy programs are most effective and which
components could be improved. For example, exit or follow-up
interviews with participants could be conducted to systematically
document and analyse participants’ responses to each of the
program components. Additionally, interviews could investigate
both intended and unintended effects of programs in order to gain
a more holistic understanding of the obtained beneﬁts. Case
studies could also be informative in this respect, especially
longitudinal case studies to further investigate longer-term
changes. It may also be an important consideration for the
development of future adventure therapy interventions to
investigate the relative beneﬁts of adventure therapy for different
client types, presenting problems, and other individual differences.
4.3. Limitations
This study found that WAT programs are reasonably effective,
however several limitations should be considered, including the
evaluation design, reliance on self-reported data, small sample
size, regression to the mean, missing data, and use of non-validated
questionnaires.
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clusions about causality are unable to be made. Use of a
comparison and/or wait-list control group could be useful in
future evaluations, and would be necessary to demonstrate the
effectiveness of WAT interventions. Inclusion of comparison and/or
control groups would also help to deal with the potential for
regression to the mean (Barnett, van der Pols, & Dobson, 2005),
given that participants in this study were pre-selected as being at-
risk. Additionally, future such studies should consider including
multiple long-term follow-up data collection points.
This study relied exclusively on empirical, self-reported data.
Adventure therapy program evaluation studies could be strength-
ened by triangulating self-reported data with interviews with
participants, and ratings and/or interviews with observers such as
parents and teachers. Incorporation of other existing data, such as
school attendance and behaviour records may also be helpful.
The small sample size (N = 36) limited the current study’s
statistical power. Future studies with larger sample sizes would
help to validate the ﬁndings of this study. Utilising a consistent,
minimal set of measurement tools for every participant would
allow for easier integration into larger data sets.
In applied, longitudinal research missing data is inevitable. The
current study is no exception, with only a small percentage of
participants completing all measures at each time point. Thus,
multiple imputation was used and can be recommended for use in
future adventure therapy research.
Two non-validated questionnaires (RQ (resilience) and CORE
FFQ (family functioning)) were used, potentially limiting the
reliability and validity of ﬁndings. Where possible, existing
psychometrically validated assessment tools should be used and
the psychometric properties of instrumentation should be
reported. A task for future adventure therapy research is the
development of purpose-built, multi-dimensional assessment
tools using the best available psychometric techniques.
5. Conclusion
The current study contributes to research literature about
psychotherapeutic effects of adventure therapy treatment for
adolescents by evaluating self-reported outcomes for 36 WAT
program adolescent participants. Overall, results indicated small,
statistically signiﬁcant improvements (ES = 0.26) which are within
the expected range of effects for adventure therapy programs with
similar target groups. Large, positive, statistically signiﬁcant
changes were evident for participants in clinical ranges for
depression and behavioural and emotional functioning. Impor-
tantly, the changes appear to have been retained at a three-month
follow-up. These ﬁndings indicate that WAT offers a potentially
viable alternative treatment modality to more traditional psycho-
therapeutic approaches for youth at-risk with clinically signiﬁcant
symptoms. More in-depth investigation using triangulated data,
qualitative and quantitative data, evaluation of speciﬁc program
components, comparison or wait-list control groups, and a larger
sample would help to better understand the obtained beneﬁts
(intended and unintended), as well as what works, how it works,
and what could be improved.
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